Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
International Journal of Clinical Pharmacy
Published in: International Journal of Clinical Pharmacy 6/2015

01-12-2015 | Commentary

NSAIDs in paediatrics: caution with varicella!

Authors: L. Durand, P. Sachs, C. Lemaitre, M. Lorrot, J. Bassehila, O. Bourdon, S. Prot-Labarthe

Published in: International Journal of Clinical Pharmacy | Issue 6/2015

Login to get access

Abstract

Anti-inflammatory drugs have been suspected on several occasions to have promoted development of bacterial infection among varicella patients. Some countries have not implemented childhood varicella vaccination. Three cases in our hospital suggested the predisposing role of NSAIDs in varicella patient deterioration. Open access to these drugs widely increases their use and patient information should be continually provided in the medical offices and at dispensing pharmacy counters. Taking account of the benefit/risk balance and applying the simple precautionary principle, it would be appropriate to be cautious about the use of NSAIDs in the paediatric population.
Literature
1.
2.
3.
4.
Bégaud B, Evreux JC, Jouglard J, Lagier G. Imputation of the unexpected or toxic effects of drugs. Actualization of the method used in France. Therapie. 1985;40(2):111–8.PubMed
5.
Kaplan HB, Edelson HS, Korchak HM, Given WP, Abramson S, Weissmann G. Effects of non-steroidal anti-inflammatory agents on human neutrophil functions in vitro and in vivo. Biochem Pharmacol. 1984;33(3):371–8.CrossRefPubMed
6.
Pontes T, Antunes H. Group A beta-hemolytic streptococcal toxic shock. Acta Med Port. 2004;17(5):395–8.PubMed
7.
Leroy S, Mosca A, Landre-Peigne C, Cosson M-A, Pons G. Ibuprofen in childhood: evidence-based review of efficacy and safety. Arch Pediatr. 2007;14(5):477–84.CrossRefPubMed
8.
Zerr DM, Alexander ER, Duchin JS, Koutsky LA, Rubens CE. A case-control study of necrotizing fasciitis during primary varicella. Pediatrics. 1999;103(4 Pt 1):783–90.CrossRefPubMed
9.
Lesko SM, O’Brien KL, Schwartz B, Vezina R, Mitchell AA. Invasive group A streptococcal infection and nonsteroidal antiinflammatory drug use among children with primary varicella. Pediatrics. 2001;107(5):1108–15.CrossRefPubMed
10.
Legras A, Giraudeau B, Jonville-Bera A-P, et al. A multicentre case-control study of nonsteroidal anti-inflammatory drugs as a risk factor for severe sepsis and septic shock. Crit Care. 2009;13(2):R43.PubMedCentralCrossRefPubMed
11.
Stevens DL. Could nonsteroidal antiinflammatory drugs (NSAIDs) enhance the progression of bacterial infections to toxic shock syndrome? Clin Infect Dis. 1995;21(4):977–80.CrossRefPubMed
12.
Voiriot G, Dury S, Parrot A, Mayaud C, Fartoukh M. Nonsteroidal antiinflammatory drugs may affect the presentation and course of community-acquired pneumonia. Chest. 2011;139(2):387–94.CrossRefPubMed
13.
Mikaeloff Y, Kezouh A, Suissa S. Nonsteroidal anti-inflammatory drug use and the risk of severe skin and soft tissue complications in patients with varicella or zoster disease. Br J Clin Pharmacol. 2008;65(2):203–9.PubMedCentralCrossRefPubMed
14.
Ulinski T, Bensman A. Renal complications of non-steroidal anti-inflammatories. Arch Pediatr. 2004;11(7):885–8.CrossRefPubMed
15.
Mounier G, Guy C, Berthoux F, Beyens MN, Ratrema M, Ollagnier M. Severe renal adverse events with arylcarboxylic non-steroidal anti-inflammatory drugs: results of a eight-year French national survey. Therapie. 2006;61(3):255–66.CrossRefPubMed
16.
Metadata
Title
NSAIDs in paediatrics: caution with varicella!
Authors
L. Durand
P. Sachs
C. Lemaitre
M. Lorrot
J. Bassehila
O. Bourdon
S. Prot-Labarthe
Publication date
01-12-2015
Publisher
Springer Netherlands
Published in
International Journal of Clinical Pharmacy / Issue 6/2015
Print ISSN: 2210-7703
Electronic ISSN: 2210-7711
DOI
https://doi.org/10.1007/s11096-015-0184-2

Other articles of this Issue 6/2015

International Journal of Clinical Pharmacy 6/2015 Go to the issue

Research Article

Demonstrating the clinical pharmacist’s activity: validation of an intervention oriented classification system

Research Article

Community pharmacist intervention in patients with renal impairment

Research Article

Knowledge and attitude of health-care professionals in hospitals towards pharmacovigilance in Saudi Arabia

Research Article

Tablet splitting of narrow therapeutic index drugs: a nationwide survey in Taiwan

Research Article

Clinical pharmacokinetics: perceptions of hospital pharmacists in Qatar about how it was taught and how it is applied

Research Article

Completeness of medication-related information in discharge letters and post-discharge general practitioner overviews

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits